TriArm Therapeutics Appoints Douglas E. Williams, Ph.D., as Chief Executive Officer [Yahoo! Finance]
Sana Biotechnology, Inc. (SANA)
Company Research
Source: Yahoo! Finance
company leveraging its global presence and core non-viral platform to advance and democratize CAR-T therapy for patients worldwide, today announced the appointment of Douglas E. Williams, Ph.D. as Chief Executive Officer (CEO). “Doug is an accomplished biopharmaceutical veteran with over 30 years of cross-functional drug development expertise, senior corporate leadership experience, proven capital markets prowess and strategic deal-making savvy, as well as a strong track record of delivering paradigm-shifting products to patients, including several blockbusters such as Enbrel®, Tecfidera®, and Spinraza®,” said James Huang, Founder and Executive Chairman of the Board of Directors of TriArm. “We are beyond delighted to welcome Doug as CEO
Read more
Impact Snapshot
Event Time:
SANA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SANA alerts
Movers & Shakers
The biggest gainers and losers and WHY it moved
SANA alerts
High impacting Sana Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
SANA
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANAAccesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANAAccesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANAAccesswire
- Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANAPR Newswire
SANA
Earnings
- 11/8/24 - Miss
SANA
Sec Filings
- 1/16/25 - Form 144
- 1/13/25 - Form 8-K
- 1/10/25 - Form 4
- SANA's page on the SEC website